AGE AT DIAGNOSIS AND MULTIPLE PRIMARY CANCERS OF THE BREAST AND OVARY

Citation
Pj. Surisswirtz et al., AGE AT DIAGNOSIS AND MULTIPLE PRIMARY CANCERS OF THE BREAST AND OVARY, Breast cancer research and treatment, 41(1), 1996, pp. 21-29
Citations number
31
Categorie Soggetti
Oncology
ISSN journal
01676806
Volume
41
Issue
1
Year of publication
1996
Pages
21 - 29
Database
ISI
SICI code
0167-6806(1996)41:1<21:AADAMP>2.0.ZU;2-6
Abstract
This nested case-control study assessed the relationship between a wom an's age at the time of her initial primary breast or ovarian cancer d iagnosis and the risk of a second primary cancer at the other of these two sites. Multiple primary breast and ovarian cancer cases whose ini tial breast or ovarian diagnosis occurred in 1970-1989 and a random sa mple of single primary breast or ovarian cancer controls diagnosed in the same years were identified through tumor registries at Duke Univer sity Medical Center and the University of North Carolina. Women diagno sed with an initial primary breast cancer at age less than or equal to 50 years were 4.3 times (95% CI: 1.8-10.6) more likely to have develo ped a subsequent ovarian cancer compared to those diagnosed after age 50. A relationship between an early age at diagnosis (less than or equ al to 50) of ovarian cancer and subsequent diagnosis of breast cancer was not found (odds ratio (OR) = 0.6; 95% CI: 0.2-2.0). Adjustment for stage at diagnosis, treatment, year of diagnosis and length of follow -up using Cox Proportional Hazards modeling techniques supported these relationships, yielding a hazard ratio (HR) for the development of a second primary cancer at the alternate site of 4.6 (95% CI: 1.8-11.5) for women with an initial breast cancer diagnosis and 0.6 (95% CI: 0.2 -2.2) for women with an initial ovarian cancer diagnosis. Multiple pri mary breast and ovarian cancer patients diagnosed with an initial brea st cancer at or prior to age 50 may represent a distinct subgroup of w omen with a germline mutation that confers susceptibility to both brea st and ovarian cancers.